Author

M. Stanley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Chuah· 1 shared A. Golas· 1 shared A. M. D. Lorenzo· 1 shared A. P. Headley· 1 shared A. T. Ferenbach· 1 shared A.-M. Hatch· 1 shared B. K. Hubbard· 1 shared C. E. Moss· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chuah

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Rare SH2B3 coding variants identified in lupus patients impair B cell tolerance and predispose to autoimmunity

Y. Zhang, R. Morris, A. M. D. Lorenzo, X. Meng, N. J. Kershaw, P. Kiridena, G. J. Brown, G. Burgio, J. Y. Cappello, Q. Shen, H. Wang, C. M. Turnbull, T. Lea-Henry, M. Stanley, Z. Yu, , J. I. Ellyard

The paper identifies rare SH2B3 variants in lupus patients that impair B cell tolerance and increase autoimmunity risk by affecting IL-4R signaling and BAFF-R expression.

bioRxiv · Apr 27, 2023 · PreprintImmunology

Targeting a critical step in fungal hexosamine biosynthesis

D. E. A. Lockhart, M. Stanley, O. G. Raimi, D. A. Robinson, D. Boldovjakova, D. R. Squair, A. T. Ferenbach, W. Fang, D. M. F. van Aalten

This study identifies Gna1 as an antifungal target in Aspergillus fumigatus by showing its essential role in cell wall synthesis and demonstrating a chemical inhibitor.

bioRxiv · Jan 7, 2020Microbiology

Large-scale chemical-genetics yields new Mycobacterium tuberculosis inhibitor classes

E. O. Johnson, E. LaVerriere, M. Stanley, E. Office, E. Meyer, T. Kawate, J. Gomez, R. E. Audette, N. Bandyopadhyay, N. Betancourt, K. Delano, I. Da Silva, J. Davis, C. Gallo, M. Gardner, , Schnappinge

This study uses a novel chemical-genetics screening strategy to identify new inhibitors of Mycobacterium tuberculosis, revealing novel compound classes targeting previously unexplored bacterial targets.

bioRxiv · Jan 16, 2019Microbiology